Aclarion, Inc. (ACON) vs Curanex Pharmaceuticals Inc Common Stock (CURX)
A side-by-side comparison of Aclarion, Inc. and Curanex Pharmaceuticals Inc Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACON
Aclarion, Inc.
$2.34HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CURX
Curanex Pharmaceuticals Inc Common Stock
$4.96HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACON vs CURX
growth of $100 · dividends reinvested · last 1yACON -67.6% (-67.6%/yr)CURX -93.8% (-93.8%/yr)ACON compounded faster over this window
Log scale — wide-divergence pair
ACON CURX
ACON vs CURX: by the numbers
- •CURX is the larger company ($7M vs $7M market cap).
- •Both run net losses; CURX's is the smaller (0.00% vs -10978.48% net margin).
Metrics side by side
Valuation
| Metric | ACON | CURX |
|---|---|---|
| P/S ratio | 80.52 | N/A |
| P/B ratio | 0.40 | 1.47 |
Profitability
| Metric | ACON | CURX |
|---|---|---|
| Gross margin | -291.27% | 0.00% |
| Operating margin | -9312.55% | 0.00% |
| Net margin | -10978.48% | 0.00% |
| ROE | -54.09% | -218.65% |
| ROIC | -57.11% | -208.39% |
Growth (annualized)
| Metric | ACON | CURX |
|---|---|---|
| Revenue CAGR (5Y) | 3.75% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.